source
- Cellares defends its cell therapy platform after Bristol Myers ends partnershipCellares, a cell therapy manufacturing startup, responded to criticism from Bristol Myers Squibb after the drugmaker terminated their agreement. Bristol Myers withdrew, saying Cellares' commercial…
- Calcium scans may guide statin decisions in a few borderline patients, studies findTwo recent trials evaluated whether coronary artery calcium (CAC) scans, used together with the PREVENT risk calculator, can help decide on statin therapy. The studies compared the imaging results…